Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus : Factors contributing to hepatocarcinogenesisCHIN, Ruth; EARNEST-SILVEIRA, Linda; KOEBERLEIN, Bernd et al.Journal of hepatology. 2007, Vol 47, Num 3, pp 325-337, issn 0168-8278, 13 p.Article

Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantationBOCK, C.-Thomas; TILLMANN, Hans L; TORRESI, Joseph et al.Gastroenterology (New York, NY. 1943). 2002, Vol 122, Num 2, pp 264-273, issn 0016-5085Article

Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in VietnamTOAN, Nguyen L; SONG, Le H; KREMSNER, Peter G et al.Hepatology (Baltimore, Md.). 2006, Vol 43, Num 6, pp 1375-1384, issn 0270-9139, 10 p.Article

Phospholipase A2 activity-dependent stimulation of Ca²⁺ entry by human parvovirus B19 capsid protein VP1LUPESCU, Adrian; BOCK, C.-Thomas; LANG, Philpp A et al.Journal of virology. 2006, Vol 80, Num 22, pp 11370-11380, issn 0022-538X, 11 p.Article

Mutation Pattern of Lamivudine Resistance in Relation to Hepatitis B Genotypes: Hepatitis B Genotypes Differ in Their Lamivudine Resistance Associated Mutation PatternDAMEROW, Hans; YUEN, Lilly; WIEGAND, Johannes et al.Journal of medical virology. 2010, Vol 82, Num 11, pp 1850-1858, issn 0146-6615, 9 p.Article

Parvovirus B19: a pathogen responsible for more than hematologic disordersBÜLTMANN, Burkhard D; KLINGEL, Karin; SOTLAR, Karl et al.Virchows Archiv. 2003, Vol 442, Num 1, pp 8-17, issn 0945-6317, 10 p.Article

Human Parvovirus B19 NS1 Protein Modulates Inflammatory Signaling by Activation of STAT3/PIAS3 in Human Endothelial CellsDUECHTING, Anja; TSCHÖPE, Carsten; KAISER, Heike et al.Journal of virology. 2008, Vol 82, Num 16, pp 7942-7952, issn 0022-538X, 11 p.Article

Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patientsTOAN, Nguyen L; DUECHTING, Anja; BOCK, C.-Thomas et al.Journal of general virology. 2006, Vol 87, pp 2941-2949, issn 0022-1317, 9 p., 10Article

Relevance of hepatitis B Core gene deletions in patients after kidney transplantationBOCK, C.-Thomas; BUERKE, Boris; TILLMANN, Hans L et al.Gastroenterology (New York, NY. 1943). 2003, Vol 124, Num 7, pp 1809-1820, issn 0016-5085, 12 p.Article

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspectiveJAROSZEWICZ, Jerzy; CALLE SERRANO, Beatriz; CORNBERG, Markus et al.Journal of hepatology. 2010, Vol 52, Num 4, pp 514-522, issn 0168-8278, 9 p.Article

Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infectionTOAN, Nguyen L; SONG, Le H; KREMSNER, Peter G et al.Journal of hepatology. 2006, Vol 45, Num 3, pp 361-369, issn 0168-8278, 9 p.Article

Presentation, patterns of myocardial damage, and clinical course of viral myocarditisMAHRHOLDT, Heiko; WAGNER, Anja; KLINGEL, Karin et al.Circulation (New York, N.Y.). 2006, Vol 114, Num 15, pp 1581-1590, issn 0009-7322, 10 p.Article

Genetic insights on host and hepatitis B virus in liver diseasesVAN TONG, Hoang; BOCK, C. Thomas; VELAVAN, Thirumalaisamy P et al.Mutation research. Reviews in mutation research. 2014, Vol 762, pp 65-75, issn 1383-5742, 11 p.Article

Molecular pathology of inflammatory cardiomyopathyKLINGEL, Karin; SAUTER, Martina; BOCK, C. Thomas et al.Medical microbiology and immunology. 2004, Vol 193, Num 2-3, pp 101-107, issn 0300-8584, 7 p.Article

Failure of lamivudine to reverse hepatitis B virus-associated changes in ERK, Akt and cell cycle regulatory proteinsCHIN, Ruth; EARNEST-SILVEIRA, Linda; KOEBERLEIN, Bernd et al.Antiviral therapy (London). 2008, Vol 13, Num 2, pp 221-230, issn 1359-6535, 10 p.Article

Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell-mediated diseaseBÜLTMANN, Burkhard D; KLINGEL, Karin; SOTLAR, Karl et al.Human pathology. 2003, Vol 34, Num 1, pp 92-95, issn 0046-8177, 4 p.Article

Intrahepatic Long-Term Persistence of Parvovirus B19 and Its Role in Chronic Viral HepatitisCHUN WANG; HEIM, Albert; KANDOLF, Reinhard et al.Journal of medical virology. 2009, Vol 81, Num 12, pp 2079-2088, issn 0146-6615, 10 p.Article

Inhibition of Hepatitis B virus replication in vivo by nucleoside analogues and siRNAKLEIN, Christian; BOCK, C. Thomas; WEDEMEYER, Heiner et al.Gastroenterology (New York, NY. 1943). 2003, Vol 125, Num 1, pp 9-18, issn 0016-5085, 10 p.Article

A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative HBeAg or HBV DNA levelsWIEGAND, Johannes; WEDEMEYER, Heiner; FINGER, Andrea et al.Antiviral therapy (London). 2008, Vol 13, Num 4, pp 547-554, issn 1359-6535, 8 p.Article

Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virusDELANEY, William E; EDWARDS, Ros; LOCARNINI, Stephen et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 6, pp 1705-1713, issn 0066-4804Article

Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantationMEDERACKE, Ingmar; FILMANN, Natalie; SAVAS, Berna et al.Journal of hepatology. 2012, Vol 56, Num 1, pp 115-122, issn 0168-8278, 8 p.Article